In summary, these novel findings demonstrate downregulation of actin cytoskeleton in whole blood samples from SMA patients and provide new insights into the contribution of SMN deficiency in tissues other than motor neurons and therapeutic targets for SMA adult patients. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.